학술논문
Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice
Document Type
Article
Author
Source
In: Journal of Dermatological Treatment . (Journal of Dermatological Treatment, 2022, 33(3):1591-1597)
Subject
Language
English
ISSN
14711753
09546634
09546634